HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Wang, Fuli ^a   Grigorieva, Elvira V ^a,b   Li, Jingfeng ^a,e   Senchenko, Vera N ^c   Pavlova, Tatiana V ^a,c   Anedchenko, Ekaterina A ^c   Anna, V Kudryavtseva ^c   Tsimanis, Alexander ^d   Angeloni, Debora ^e,f   Lerman, Michael I ^e   Kashuba, Vladimir I ^a,g   Klein, George ^a   Zabarovsky, Eugene R ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

^c ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^d Bioactivity Ltd   (Israel)

^e NATIONAL CANCER INSTITUTE   (United States)

^f INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^g INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONOGLUCOSAMINIDASE; HYALURONOGLUCOSAMINIDASE 1; HYALURONOGLUCOSAMINIDASE 2; PROTEIN P53; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; HYAL2 PROTEIN, HUMAN; LYSOSOMAL HYALURONIDASE HYAL 1, MOUSE; LYSOSOMAL HYALURONIDASE HYAL-1, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL INTERACTION; CELL PROLIFERATION; CLEAR CELL CARCINOMA; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE DELETION; GENETIC TRANSFECTION; GROWTH CURVE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; KIDNEY CARCINOMA; LUNG SMALL CELL CANCER; MICROENVIRONMENT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCID MOUSE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; ANIMAL; CELL DIVISION; CLONOGENIC ASSAY; DRUG EFFECT; GENETICS; KIDNEY TUMOR; LUNG TUMOR; METHODOLOGY; MOUSE MUTANT; PATHOLOGY; TUMOR CELL LINE;

MUS;

ANIMALS; CELL ADHESION MOLECULES; CELL DIVISION; CELL LINE, TUMOR; COLONY-FORMING UNITS ASSAY; HUMANS; HYALURONOGLUCOSAMINIDASE; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; MICE, SCID; TRANSFECTION;

EID: 52649130897     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003031     Document Type: Article

References (32)

1. Alimov A, Kost-Alimova M, Liu J, Li C, Bergerheim U, et al. (2000) Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma. Oncogene 19: 1392-1399.
2. Braga E, Senchenko V, Bazov I, Loginov W, Liu J, et al. (2002) Critical tumour-suppressor gene regions on chromosome 3P in major human epithelial malignancies: allelotyping and quantitative real-time PCR. Int J Cancer 100: 534-541.
3. Li J, Protopopov A, Wang F, Senchenko V, Petushkov V, Vorontsova O, et al. (2002) NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes. Proc Natl Acad Sci U S A 99: 10724-10729.
4. Senchenko V, Liu J, Braga E, Mazurenko N, Loginov W, et al. (2003) Deletion mapping using quantitative real-time PGR identifies two distinct 3p21.3 regions affected in most cervical carcinomas. Oncogene 22: 2984-2992.
5. Senchenko VN, Liu J, Loginov W, Bazov I, Angeloni D, et al. (2004) Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 23: 5719-5728.
6. Lerman MI, Minna JD (2000) The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumour suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumour Suppressor Gene Consortium. Cancer Res 60: 6116-6133.
7. Zabarovsky ER, Lerman MI, Minna JD (2002) Tumour suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 21: 6915-6935.
8. Protopopov A, Kashuba VI, Zabarovska VI, Muravenko OV, Lerman MI, et al. (2003) An Integrated Physical and Gene Map of the 3.5-Mb Chromosome 3p21.3 (AP20) Region Implicated in Major Human Epithelial Malignancies. Cancer Research 63: 404-412.
9. Kashutba VI, Li J, Wang F, Senchenko VN, Protopopov A, et al. (2004) RBSP3 (HYA22) is a tumour suppressor gene implicated in major epithelial malignancies. Proc Natl Acad Sci U S A 101: 4906-4911.
10. Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA (2002) The RASSF1A tumour suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 22: 4309-4318.
11. Irmeh S, Klein G, Zabarovsky ER (2003) Search for unknown tumour-antagonizing genes. Genes Chromosomes Cancer 38: 307-321.
12. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, et al. (2001) Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93: 691-699.
13. Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, et al. (2001) The candidate tumour suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumourigenesis. Proc Natl Acad Sci U S A 98: 7504-7509.
14. Li J, Wang F, Protopopov A, Malyukova A, Kashuba V, et al. (2004) Inactivation of RASSF1C during in vivo tumour growth identifies it as a tumour suppressor gene. Oncogene 23: 5941-5949.
15. Li J, Wang F, Malyukova A, Protopopov A, Duh F-M, et al. (2004) Functional characterization of the candidate tumour suppressor gene NPRL2/G21 located in 3p21.3C. Cancer Research 64: 6438-6443.
16. Rai SK, Duh FM, Vigdorovich V, Danilkovitch-Miagkova A, Lerman MI, et al. (2001) Candidate tumour suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci U S A 98: 4443-4448.
17. Danilkovitch-Miagkova A, Duh FM, Kuzmin I, Angeloni D, Liu SL, et al. (2003) Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsickte sheep retrovirus. Proc Natl Acad Sci U S A 100: 4580-4585.
18. Harada H, Takahashi M (2007) GD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J Biol Chem 282: 5597-5607.
19. Harris H, Miller OJ, Klein G, Worst P, Tachibana T (1969) Suppression of malignancy by cell fusion. Nature 223: 363-368.
20. Harris H, Wiener F, Mein G (1971) The analysis of malignancy by cell fusion. 3. Hybrids between diploid fibroblasts and other tumour cells. J Cell Sci 8: 681-92.
21. Protopopov AI, Li J, Winberg G, Gizatullin RZ, Kashuba VI, et al. (2002) Human cell lines engineered for tetracycline-regulated expression of tumour suppressor candidate genes from a frequently affected chromosomal region, 3p21. J Gene Med 4: 397-406.
22. Li J, Protopopov AI, Gizatullin RZ, Kiss C, Kashuba VI, et al. (1999) Identification of new tumour suppressor genes based on in vivo functional inactivation of a candidate gene. FEBS Lett 451: 289-294.
23. Csoka AB, Frost GI, Stern R (2001) The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol 20: 499-508.
24. Zhang L, Underhill CB, Chen L (1995) Hyaluronan on the surface of tumour cells is correlated with metastatic behavior. Cancer Res 55: 428-433.
25. Kosaki R, Watanabe K, Yamaguchi Y (1999) Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumourigenicity. Cancer Res 59: 1141-1145.
26. Liu N, Gao F, Han Z, Xu X, Underhill CB, et al. (2001) Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Res 61: 5207-5214.
27. Frost GI, Mohapatra G, Wong TM, Csoka AB, Gray JW, et al. (2000) HYAL1LUCA-1, a candidate tumour suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA. Oncogene 19: 870-877.
28. Ji L, Nishizaki M, Gao B, Burbee D, Kondo M, et al. (2002) Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res 62: 2715-2720.
29. Klein G, Imreh S, Zabarovsky ER (2007) Why do we not all die of cancer at an early age? Adv. Cancer Research 98: 1-16.
30. Heppell-Parton AC, Nacheva E, Carter NP, Rabbitts PH (1999) A combined approach of conventional and molecular cytogenetics for detailed karyotypic analysis of the small cell lung carcinoma cell line U2020. Cancer Genet Cytogenet 108: 110-119.
31. Zabarovsky ER, Boldog F, Thompson T, Scanlon D, Winberg G, et al. (1990) Construction of a human chromosome 3 specific NotI linking library using a novel cloning procedure. Nucleic Acids Res 18: 6319-6324.
32. Glantz SA (1994) Primer of biostatistics. 4th edition. NY: McGraw-Hill, Inc. pp 1-459.